Showing results (1-10 of 812) with videos related to
Sort By:
Pageof 82
Cancer Cell|February 9, 2021
Not All Tumor-Infiltrating CD8+ T Cells Are Created EqualWerner Held, Daniel E SpeiserThe Journal of Clinical Investigation|June 3, 2005
Toward improved immunocompetence of adoptively transferred CD8+ T cellsDaniel E Speiser, Pedro RomeroSeminars in Immunology|April 24, 2010
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunityDaniel E Speiser, Pedro RomeroBlood|September 28, 2002
Mouse CD11c(+) B220(+) Gr1(+) plasmacytoid dendritic cells develop independently of the T-cell lineageIsabel Ferrero, Werner Held, Anne Wilson, et al.Science Translational Medicine|October 25, 2019
Intratumoral CD8+ T cells with stem cell-like properties: Implications for cancer immunotherapyWerner Held, Imran Siddiqui, Karin Schaeuble, et al.Expert Opinion on Therapeutic Targets|December 15, 2010
The CD4-like molecule LAG-3, biology and therapeutic applicationsSophie Sierro, Pedro Romero, Daniel E SpeiserEuropean Journal of Immunology|August 27, 2014
Deciphering the unusual HLA-A2/Melan-A/MART-1-specific TCR repertoire in humansPedro Romero, Daniel E Speiser, Nathalie RuferCancer Immunity|May 16, 2003
Can hTERT peptide (540-548) -specific CD8 T cells recognize and kill tumor cells?Daniel E Speiser, Jean-Charles Cerottini, Pedro RomeroAdvances in Immunology|December 6, 2006
The human T cell response to melanoma antigensPedro Romero, Jean-Charles Cerottini, Daniel E SpeiserCancer Immunology, Immunotherapy : CII|January 6, 2004
Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccinationPedro Romero, Jean-Charles Cerottini, Daniel E SpeiserPageof 82